2020, Number 4
<< Back
Medicina & Laboratorio 2020; 24 (4)
Erythropoietin (EPO)
de los Ríos-Morales LA, Guevara-Arismendy NM, Vizcaíno-Carruyo JC, Toro-Montoya AI
Language: Spanish
References: 5
Page: 344-347
PDF size: 243.19 Kb.
Text Extraction
No abstract.
REFERENCES
Beckman Coulter. Access EPO. Erythropoietin, ref A1636. California, USA: Beckman Coulter. Acceso 22 de agosto de 2020. Disponible en https://www.beckmancoulter. com/download/file/phxA88209K-EN_US/ A88209K?type=pdf.
Tefferi A, Barbui T. Polycythemia vera and essential thrombocythemia: 2019 update on diagnosis, risk-stratification and management. Am J Hematol 2019;94:133-143. https://doi. org/10.1002/ajh.25303.
Cullis JO. Diagnosis and management of anaemia of chronic disease: current status. Br J Haematol 2011;154:289-300. https://doi. org/10.1111/j.1365-2141.2011.08741.x.
Mikhail A, Brown C, Williams JA, Mathrani V, Shrivastava R, Evans J, et al. Renal association clinical practice guideline on anaemia of chronic kidney disease. BMC nephrology 2017;18:345- 345. https://doi.org/10.1186/s12882-017-0688-1.
Bohlius J, Bohlke K, Castelli R, Djulbegovic B, Lustberg MB, Martino M, et al. Management of cancer-associated anemia with erythropoiesis-stimulating agents: ASCO/ASH clinical practice guideline update. J Clin Oncol 2019;37:1336-1351. https://doi.org/10.1200/ jco.18.02142.
Full text